Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-24-000460
Filing Date
2024-08-14
Accepted
2024-08-14 11:04:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2720
  Complete submission text file 0001949846-24-000460.txt   4155
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38485 | Film No.: 241205279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Shah Nikita (Reporting) CIK: 0001738061 (see all company filings)

Type: 144